{"entity":{"type":"insider","cik":"0001682019","url":"/insider/0001682019","json_url":"/insider/0001682019.json","name":"Kulkarni Samarth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":107,"n_filings":47,"first":"2017-04-21","last":"2026-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Kulkarni Samarth","source":"filing","n_filings":47,"first_seen":"2017-04-21","last_seen":"2026-03-24"}],"transactions":[{"id":5822771,"accession":"0001193125-26-122272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-122272","line_url":"/filing/0001193125-26-122272#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10020.0,"shares_display":"10,020","price_per_share":46.78,"price_display":"46.78","price_state":"stated","total_value":468735.6,"total_display":"468,735.60","total_whole":"468,736","shares_owned_after":255501.0,"shares_owned_after_display":"255,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-23","filed_date":"2026-03-24","scope":"insider"},{"id":6016765,"accession":"0001193125-26-111278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-111278","line_url":"/filing/0001193125-26-111278#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10349.0,"shares_display":"10,349","price_per_share":48.26,"price_display":"48.26","price_state":"stated","total_value":499442.74,"total_display":"499,442.74","total_whole":"499,443","shares_owned_after":245834.0,"shares_owned_after_display":"245,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":6001594,"accession":"0001193125-26-104480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-104480","line_url":"/filing/0001193125-26-104480#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9798.0,"shares_display":"9,798","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":517334.4,"total_display":"517,334.40","total_whole":"517,334","shares_owned_after":235558.0,"shares_owned_after_display":"235,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-12","scope":"insider"},{"id":5836598,"accession":"0001193125-26-061712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-061712","line_url":"/filing/0001193125-26-061712#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6967.0,"shares_display":"6,967","price_per_share":52.58,"price_display":"52.58","price_state":"stated","total_value":366324.86,"total_display":"366,324.86","total_whole":"366,325","shares_owned_after":226106.0,"shares_owned_after_display":"226,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-19","filed_date":"2026-02-20","scope":"insider"},{"id":5770355,"accession":"0001193125-26-019733","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-019733","line_url":"/filing/0001193125-26-019733#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":60.23,"price_display":"60.23","price_state":"stated","total_value":3613800.0,"total_display":"3,613,800.00","total_whole":"3,613,800","shares_owned_after":134201.0,"shares_owned_after_display":"134,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-22","scope":"insider"},{"id":5770351,"accession":"0001193125-26-019733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-019733","line_url":"/filing/0001193125-26-019733","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":51.749927666666665,"price_display":"51.75","price_state":"stated","total_value":1552497.83,"total_display":"1,552,497.83","total_whole":"1,552,498","shares_owned_after":202768.0,"shares_owned_after_display":"202,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider","n_lines":2},{"id":4298250,"accession":"0001193125-25-243819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-243819","line_url":"/filing/0001193125-25-243819#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50895.0,"shares_display":"50,895","price_per_share":67.91,"price_display":"67.91","price_state":"stated","total_value":3456279.45,"total_display":"3,456,279.45","total_whole":"3,456,279","shares_owned_after":254201.0,"shares_owned_after_display":"254,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-20","scope":"insider"},{"id":4940350,"accession":"0001193125-25-240438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-240438","line_url":"/filing/0001193125-25-240438#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4242.0,"shares_display":"4,242","price_per_share":66.6,"price_display":"66.60","price_state":"stated","total_value":282517.2,"total_display":"282,517.20","total_whole":"282,517","shares_owned_after":205096.0,"shares_owned_after_display":"205,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-14","filed_date":"2025-10-15","scope":"insider"},{"id":4438216,"accession":"0001682019-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001682019-25-000003","line_url":"/filing/0001682019-25-000003#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13081.0,"shares_display":"13,081","price_per_share":58.15,"price_display":"58.15","price_state":"stated","total_value":760660.15,"total_display":"760,660.15","total_whole":"760,660","shares_owned_after":207004.0,"shares_owned_after_display":"207,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4583470,"accession":"0000950170-25-043975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043975","line_url":"/filing/0000950170-25-043975#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10031.0,"shares_display":"10,031","price_per_share":41.23,"price_display":"41.23","price_state":"stated","total_value":413578.13,"total_display":"413,578.13","total_whole":"413,578","shares_owned_after":195085.0,"shares_owned_after_display":"195,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-21","filed_date":"2025-03-24","scope":"insider"},{"id":5074127,"accession":"0000950170-25-038216","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-038216","line_url":"/filing/0000950170-25-038216#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4462.0,"shares_display":"4,462","price_per_share":43.32,"price_display":"43.32","price_state":"stated","total_value":193293.84,"total_display":"193,293.84","total_whole":"193,294","shares_owned_after":185428.0,"shares_owned_after_display":"185,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-12","scope":"insider"},{"id":5074120,"accession":"0000950170-25-038216","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-038216","line_url":"/filing/0000950170-25-038216#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9973.0,"shares_display":"9,973","price_per_share":42.42,"price_display":"42.42","price_state":"stated","total_value":423054.66,"total_display":"423,054.66","total_whole":"423,055","shares_owned_after":180890.0,"shares_owned_after_display":"180,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4582496,"accession":"0000950170-25-023385","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-023385","line_url":"/filing/0000950170-25-023385#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6928.0,"shares_display":"6,928","price_per_share":52.8,"price_display":"52.80","price_state":"stated","total_value":365798.4,"total_display":"365,798.40","total_whole":"365,798","shares_owned_after":189973.0,"shares_owned_after_display":"189,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4059309,"accession":"0000950170-25-025000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-025000","line_url":"/filing/0000950170-25-025000#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18360.0,"shares_display":"18,360","price_per_share":55.205,"price_display":"55.20","price_state":"stated","total_value":1013563.8,"total_display":"1,013,563.80","total_whole":"1,013,564","shares_owned_after":171613.0,"shares_owned_after_display":"171,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":4582491,"accession":"0000950170-25-023385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-023385","line_url":"/filing/0000950170-25-023385#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11640.0,"shares_display":"11,640","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":640782.0,"total_display":"640,782.00","total_whole":"640,782","shares_owned_after":196901.0,"shares_owned_after_display":"196,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider"},{"id":2039951,"accession":"0000950170-24-133373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-133373","line_url":"/filing/0000950170-24-133373#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":55.1043,"price_display":"55.10","price_state":"stated","total_value":826564.5,"total_display":"826,564.50","total_whole":"826,565","shares_owned_after":181540.0,"shares_owned_after_display":"181,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2590889,"accession":"0000950170-24-126521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-126521","line_url":"/filing/0000950170-24-126521","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":55.622612,"price_display":"55.62","price_state":"stated","total_value":1668678.36,"total_display":"1,668,678.36","total_whole":"1,668,678","shares_owned_after":203419.0,"shares_owned_after_display":"203,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider","n_lines":2},{"id":2277572,"accession":"0000950170-24-114786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-114786","line_url":"/filing/0000950170-24-114786#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4293.0,"shares_display":"4,293","price_per_share":46.28,"price_display":"46.28","price_state":"stated","total_value":198680.04,"total_display":"198,680.04","total_whole":"198,680","shares_owned_after":226540.0,"shares_owned_after_display":"226,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-14","filed_date":"2024-10-15","scope":"insider"},{"id":2275376,"accession":"0000950170-24-045196","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-045196","line_url":"/filing/0000950170-24-045196","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19582.0,"shares_display":"19,582","price_per_share":59.9137738433255,"price_display":"59.91","price_state":"stated","total_value":1173231.5194,"total_display":"1,173,231.52","total_whole":"1,173,232","shares_owned_after":209326.0,"shares_owned_after_display":"209,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-17","scope":"insider","n_lines":2},{"id":2081281,"accession":"0000950170-24-032989","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-032989","line_url":"/filing/0000950170-24-032989","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":72.481407785,"price_display":"72.48","price_state":"stated","total_value":1449628.1557,"total_display":"1,449,628.16","total_whole":"1,449,628","shares_owned_after":217509.0,"shares_owned_after_display":"217,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider","n_lines":2},{"id":2459500,"accession":"0000950170-24-030189","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-030189","line_url":"/filing/0000950170-24-030189#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4583.0,"shares_display":"4,583","price_per_share":74.44,"price_display":"74.44","price_state":"stated","total_value":341158.52,"total_display":"341,158.52","total_whole":"341,159","shares_owned_after":208122.0,"shares_owned_after_display":"208,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2459496,"accession":"0000950170-24-030189","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-030189","line_url":"/filing/0000950170-24-030189#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9802.0,"shares_display":"9,802","price_per_share":78.26,"price_display":"78.26","price_state":"stated","total_value":767104.52,"total_display":"767,104.52","total_whole":"767,105","shares_owned_after":203705.0,"shares_owned_after_display":"203,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":3151186,"accession":"0000950170-24-018174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-018174","line_url":"/filing/0000950170-24-018174#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6370.0,"shares_display":"6,370","price_per_share":79.67,"price_display":"79.67","price_state":"stated","total_value":507497.9,"total_display":"507,497.90","total_whole":"507,498","shares_owned_after":194257.0,"shares_owned_after_display":"194,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-21","scope":"insider"},{"id":2066272,"accession":"0000950170-24-016574","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-016574","line_url":"/filing/0000950170-24-016574","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":80.3588731,"price_display":"80.36","price_state":"stated","total_value":1607177.462,"total_display":"1,607,177.46","total_whole":"1,607,177","shares_owned_after":194428.0,"shares_owned_after_display":"194,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-15","filed_date":"2024-02-16","scope":"insider","n_lines":3},{"id":2767034,"accession":"0000950170-24-009505","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-009505","line_url":"/filing/0000950170-24-009505","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":60.5114538,"price_display":"60.51","price_state":"stated","total_value":3025572.69,"total_display":"3,025,572.69","total_whole":"3,025,573","shares_owned_after":188077.0,"shares_owned_after_display":"188,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider","n_lines":2},{"id":2139901,"accession":"0000950170-24-005492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-005492","line_url":"/filing/0000950170-24-005492#line-2","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":62.5029,"price_display":"62.50","price_state":"stated","total_value":1250058.0,"total_display":"1,250,058.00","total_whole":"1,250,058","shares_owned_after":187377.0,"shares_owned_after_display":"187,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8545369,"accession":"0001209191-23-033394","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-033394","line_url":"/filing/0001209191-23-033394","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":64.875769888,"price_display":"64.88","price_state":"stated","total_value":1621894.2472,"total_display":"1,621,894.25","total_whole":"1,621,894","shares_owned_after":389777.0,"shares_owned_after_display":"389,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider","n_lines":4},{"id":8111701,"accession":"0001209191-23-025901","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-025901","line_url":"/filing/0001209191-23-025901","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":50.665503012,"price_display":"50.67","price_state":"stated","total_value":1266637.5753,"total_display":"1,266,637.58","total_whole":"1,266,638","shares_owned_after":391770.0,"shares_owned_after_display":"391,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-25","filed_date":"2023-04-27","scope":"insider","n_lines":2},{"id":8250127,"accession":"0001209191-23-021911","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-021911","line_url":"/filing/0001209191-23-021911","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":44.460140764,"price_display":"44.46","price_state":"stated","total_value":1111503.5191,"total_display":"1,111,503.52","total_whole":"1,111,504","shares_owned_after":392658.0,"shares_owned_after_display":"392,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-31","scope":"insider","n_lines":2},{"id":7994652,"accession":"0001209191-23-014273","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014273","line_url":"/filing/0001209191-23-014273","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":48.24973424,"price_display":"48.25","price_state":"stated","total_value":1206243.356,"total_display":"1,206,243.36","total_whole":"1,206,243","shares_owned_after":377088.0,"shares_owned_after_display":"377,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider","n_lines":3},{"id":8182565,"accession":"0001209191-23-005769","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-005769","line_url":"/filing/0001209191-23-005769","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":51.4719008,"price_display":"51.47","price_state":"stated","total_value":1286797.52,"total_display":"1,286,797.52","total_whole":"1,286,798","shares_owned_after":369111.0,"shares_owned_after_display":"369,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider","n_lines":2},{"id":6257500,"accession":"0001209191-22-063026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-063026","line_url":"/filing/0001209191-22-063026","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":40.93160112,"price_display":"40.93","price_state":"stated","total_value":1023290.028,"total_display":"1,023,290.03","total_whole":"1,023,290","shares_owned_after":373745.0,"shares_owned_after_display":"373,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider","n_lines":2},{"id":6854630,"accession":"0001209191-22-059060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-059060","line_url":"/filing/0001209191-22-059060#line-4","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17118.0,"shares_display":"17,118","price_per_share":53.5837,"price_display":"53.58","price_state":"stated","total_value":917245.7766,"total_display":"917,245.78","total_whole":"917,246","shares_owned_after":298161.0,"shares_owned_after_display":"298,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-30","scope":"insider"},{"id":6854629,"accession":"0001209191-22-059060","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-059060","line_url":"/filing/0001209191-22-059060#line-3","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001682019","owner_name":"Kulkarni Samarth","owner_display_name":"Kulkarni Samarth","owner_url":"/insider/0001682019","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5572.0,"shares_display":"5,572","price_per_share":54.8453,"price_display":"54.85","price_state":"stated","total_value":305598.0116,"total_display":"305,598.01","total_whole":"305,598","shares_owned_after":292589.0,"shares_owned_after_display":"292,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-28","filed_date":"2022-11-30","scope":"insider"}],"collapsed":true,"next_cursor":"2022-11-28|6854629","ledger_fault":false,"count":{"value":107,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":107,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":107},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director, Officer (Chief Executive Officer)","n_filings":47,"first_seen":"2017-04-21","last_seen":"2026-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682019","retrieved_at":"2026-08-22T09:13:41+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}